How OrenAI
Transforms Detection
OrenAI fuses AI perception with AR visualization and voice navigation to help clinicians discover early-stage breast cancer signals.
The Detection Journey
Scroll horizontally →
Core Capabilities
Enhanced Visibility
Transforms breast imaging scans into interactive 3D representations, highlighting potential cancer indicators—microcalcifications, suspicious masses, and tissue density anomalies—without exposing patient identity.
Contextual Exploration
Presents findings in context, allowing clinicians to see relationships across mammograms and tomosynthesis scans without relying on isolated views, enabling comprehensive cancer detection analysis.
Hands-Free
AR overlays and voice commands enable natural interaction with breast imaging data, allowing zoom, navigation, and highlighting without touching a screen, integrating smoothly into clinical workflows.
Secure Access
All processing occurs within OrenAI's portal using de-identified uploads, ensuring instant visual insights for cancer detection without transmitting sensitive patient data in a fully private environment.
What Makes OrenAI Different
No Hospital Integration Required
Works entirely through a secure portal. Clinicians can start detecting cancer signals immediately—no IT teams, no infrastructure changes.
Unified AI + AR + Voice Platform
The first to combine AI perception, AR visualization, and voice navigation in one integrated platform. No switching between systems.
Instant Access, Zero Setup
Delivers insights in seconds after upload—no training sessions, no complex workflows, no waiting for IT approval.
Designed for Individual Clinicians
Built for the clinician, not the enterprise. Scales from individual practitioners to large teams without requiring organizational buy-in.
Transparent Pricing
No per-seat licensing fees, no infrastructure costs, no integration fees. Usage-based pricing accessible to clinicians at any scale.
Continuous Learning
Improves with every scan analyzed, automatically enhancing detection accuracy over time without additional configuration.
Impact
Targets 20% reduction in missed cancer cases by fusing multimodal AI perception with AR-enhanced visualization.
Aims to accelerate clinical review time by 30% through seamless AI analysis, AR overlays, and hands-free voice navigation.
Targets early-stage detection to help achieve 99% survival rates through multimodal fusion at the most treatable stage.
Ready to transform detection?
Discover how OrenAI can help clinicians detect early-stage breast cancer signals faster and more accurately.